# Carbetocin at Elective Cesarean Delivery Part 3

> **NCT01651130** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 40 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT01651130
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651130, "Carbetocin at Elective Cesarean Delivery Part 3". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01651130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*